Deltex Medical is a global leader in haemodynamic monitoring technology. Its unique oesophageal Doppler monitoring (ODM) platform delivers accurate, real time information to guide anaesthetists on administration of fluid and drugs in surgical patients. ODM is supported by unsurpassed clinical evidence from many peer-reviewed trials. The ODM system is proven to help clinicians deliver improved surgical outcomes, fewer complications and shorter patient stay in hospital. The latest randomised, controlled, multicentre study, FEDORA, saw overall risk of complication halved, and even more dramatic reduction in specific complications such as acute kidney injury. Now Deltex Medical has added new functionality to its ODM platform that makes the system applicable across all hospital monitoring demands. High Definition Impedance Cardiography (HD-ICG), Pulse Pressure Waveform Analysis (PPWA) and Velocity/Pressure (VP) Loops software combine in what the company calls TrueVue. The clinical evidence strongly supports making haemodynamic monitoring standard of care. Deltex Medical provides best-in-class technologies in one platform to make this possible.